Facility Design and Engineering

Aug 16, 2017
By BioPharm International Editors
GlaxoSmithKline (GSK) opened a new vaccine manufacturing facility in Montrose, Scotland. The £44 million (US$57 million) facility will be used to manufacture aluminum salts, which are used for vaccine production.
Aug 10, 2017
By BioPharm International Editors
The acquisition adds sterile manufacturing capability to the CDMO’s services, which include API formulation and manufacturing.
Aug 07, 2017
By BioPharm International Editors
The Washington-headquartered biotech firm plans to use the newly purchased facility to produce antibodies for its current and future pipeline.
Jul 26, 2017
By BioPharm International Editors
Lonza introduces new modular complex that offers flexibility and individually tailored solutions to biomanufacturing challenges.
Jun 29, 2017
By BioPharm International Editors
The company broke ground on a R&D and process development facility in Missouri.
May 01, 2017
BioPharm International
Improving the bioreactor growth environment increases the rigor of bioprocessing runs.
Apr 01, 2017
BioPharm International
Understanding the purpose of the biological indicator can guide the development of an effective sterilization process.
Mar 27, 2017
By BioPharm International Editors
The Basel office will house the clinical development team and other functions to progress the company’s lead compound emapalumab.
Mar 01, 2017
BioPharm International
The process control and automation requirements of single-use systems differ from those of stainless-steel equipment.
Feb 21, 2017
Momenta’s fill/finish contract manufacturer, Pfizer, was cited in the letter.
native1_300x100
lorem ipsum